Zhu Yiping, Wang Anrong, Li Ruliu, Zhu Huibin, Hu Ling, Chen Weiwen
Pi-wei Institute, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, 12 Jichang road, Guangzhou 510405, PR China.
Saudi Pharm J. 2021 Oct;29(10):1223-1232. doi: 10.1016/j.jsps.2021.09.007. Epub 2021 Sep 20.
Epithelial cell proliferation has been demonstrated to be a critical modality for mucosal repair after gastrointestinal mucosal injury. This research aimed to investigate the effect of total ginsenosides upon the proliferation of intestinal epithelial cells (IEC-6), and elucidate its potential mechanisms through polyamine-regulated pathway including the expression of proliferation-related proteins. Total ginsenosides (PGE3) were extracted from , a Chinese herbal medicine, whose chromatogram was obtained by high performance liquid chromatographic method with evaporative light scattering detection (HPLC-ELSD). The cell proliferation, cell cycle distribution and the level of c-Myc, RhoA, Cdk2 proteins were detected to determine the effects of PGE3 at 25, 50 and100 mg/l doses on IEC-6. Furthermore, rats model of intestinal mucosal injury were induced by the subcutaneous injection of indomethacin, and the effect of aqueous extracts (PGE1) on intestinal mucosal injury was observed. PGE3 could promote IEC-6 cell proliferation, reduce the proportion of G0/G1 phase cells and elevate the proportion of G2/M + S phase cells, and revert the proliferation and cell cycle arrest induced by DFMO (DL-a-difluoromethylornithine, an inhibitor of polyamines synthesis). PGE3 exposure enhanced the level of c-Myc, RhoA and Cdk2 proteins, and reversed the inhibition of these proteins expression induced by DFMO. The results of gross and pathological scores showed administration of PGE1 significantly alleviated intestinal mucosal injury of rats. Our findings indicate that total ginsenosides promoted the IEC-6 proliferation presumably via its regulation on cell cycle and the expression of proliferation-related proteins regulated by polyamines, and provided a novel perspective for exploring the repair effect of upon gastrointestinal mucosal injury.
上皮细胞增殖已被证明是胃肠道黏膜损伤后黏膜修复的关键方式。本研究旨在探讨总人参皂苷对肠上皮细胞(IEC-6)增殖的影响,并通过多胺调节途径阐明其潜在机制,包括增殖相关蛋白的表达。总人参皂苷(PGE3)从一种中药材中提取,其色谱图通过高效液相色谱法结合蒸发光散射检测(HPLC-ELSD)获得。检测细胞增殖、细胞周期分布以及c-Myc、RhoA、Cdk2蛋白水平,以确定25、50和100mg/l剂量的PGE3对IEC-6的影响。此外,通过皮下注射消炎痛诱导大鼠肠黏膜损伤模型,观察水提取物(PGE1)对肠黏膜损伤的影响。PGE3可促进IEC-6细胞增殖,降低G0/G1期细胞比例,提高G2/M + S期细胞比例,并逆转由DFMO(DL-α-二氟甲基鸟氨酸,一种多胺合成抑制剂)诱导的增殖和细胞周期阻滞。PGE3处理可提高c-Myc、RhoA和Cdk2蛋白水平,并逆转由DFMO诱导的这些蛋白表达的抑制。大体和病理评分结果显示,给予PGE1可显著减轻大鼠肠黏膜损伤。我们的研究结果表明,总人参皂苷可能通过调节细胞周期和多胺调节的增殖相关蛋白表达来促进IEC-6增殖,并为探索其对胃肠道黏膜损伤的修复作用提供了新的视角。